| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology and Genetics |
National Cancer Institute, IST, 16132 Genoa, Italy [L. C. B., M. R. M.]; Department of Experimental Medicine, Biochemistry Section, University of Genoa, 16132 Genoa, Italy [S. S., G. D., U. B.]; The Rockefeller University, 1230 York Avenue, New York, New York 10021 [V. G. A., P. L. M.]; and Population Council, 1230 York Avenue, New York, New York 10021 [P. L. M.]
Peptide nucleic acids (PNAs) are synthetic structural analogues of DNA and RNA that, if allowed to enter the cell, bind to the complementary polynucleotide sequence and inhibit DNA transcription and mRNA translation. Although PNAs have a very limited ability in penetrating nuclei of living cells, there are indications that covalent linkage of the PNA to appropriate vectors, e.g., a nuclear localization signal, permits access to the genome. Here we test the ability of dihydrotestosterone (T) covalently linked to PNA to act as a vector for targeting c-myc DNA to prostatic cancer cell nuclei. LNCaP cells, which express the androgen receptor gene, and DU145 cells, in which the androgen receptor gene is silent, offer a model to test this biologically active hormone as a cell-specific vector. T vector was covalently linked to the NH2-terminal position of a PNA complementary to a unique sequence of c-myc oncogene (PNAmyc-T). To localize PNAmyc-T and vector-free PNA within the cells, a rhodamine (R) group was attached at the COOH-terminal position (PNAmyc-R, PNAmyc-TR); cellular uptake was monitored by confocal fluorescence microscopy. PNAmyc-R was detected only in the cytoplasm of both prostatic cell lines, whereas PNAmyc-TR was localized in nuclei as well as in cytoplasm of LNCaP cells. In contrast, PNAmyc-TR uptake in DU145 cells was minimal and exclusively cytoplasmic. In LNCaP cells, MYC protein remained unchanged by exposure to vector-free PNAmyc, whereas a significant and persistent decrease was induced by PNAmyc-T. In DU145 cells, MYC expression was unaltered by PNAmyc with or without the T vector. Our data show that the T vector facilitates cell-selective nuclear localization of PNA and its consequent inhibition of c-myc expression. These findings suggest a strategy for targeting of cell-specific anti-gene therapy in prostatic carcinoma.
This article has been cited by other articles:
![]() |
R. Ge, J. E. Heinonen, M. G. Svahn, A. J. Mohamed, K. E. Lundin, and C. I. E. Smith Zorro locked nucleic acid induces sequence-specific gene silencing FASEB J, June 1, 2007; 21(8): 1902 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tonelli, S. Purgato, C. Camerin, R. Fronza, F. Bologna, S. Alboresi, M. Franzoni, R. Corradini, S. Sforza, A. Faccini, et al. Anti-gene peptide nucleic acid specifically inhibits MYCN expression in human neuroblastoma cells leading to cell growth inhibition and apoptosis Mol. Cancer Ther., May 1, 2005; 4(5): 779 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Tian, M. R. Aruva, W. Qin, W. Zhu, K. T. Duffy, E. R. Sauter, M. L. Thakur, and E. Wickstrom External Imaging of CCND1 Cancer Gene Activity in Experimental Human Breast Cancer Xenografts with 99mTc-Peptide-Peptide Nucleic Acid-Peptide Chimeras J. Nucl. Med., December 1, 2004; 45(12): 2070 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shiraishi and P. E. Nielsen Down-regulation of MDM2 and activation of p53 in human cancer cells by antisense 9-aminoacridine-PNA (peptide nucleic acid) conjugates Nucleic Acids Res., September 15, 2004; 32(16): 4893 - 4902. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jiankuo, W. Xingbing, H. Baojun, W. Xiongwin, L. Zhuoya, X. Ping, X. Yong, L. Anting, H. Chunsong, G. Feili, et al. Peptide Nucleic Acid Antisense Prolongs Skin Allograft Survival by Means of Blockade of CXCR3 Expression Directing T Cells into Graft J. Immunol., February 1, 2003; 170(3): 1556 - 1565. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rapozzi, B. E. A. Burm, S. Cogoi, G. A. van der Marel, J. H. van Boom, F. Quadrifoglio, and L. E. Xodo Antiproliferative effect in chronic myeloid leukaemia cells by antisense peptide nucleic acids Nucleic Acids Res., September 1, 2002; 30(17): 3712 - 3721. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |